Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the cell therapy with bone marrow
mononuclear cells is safe in the treatment of chronic obstructive pulmonary disease,
specifically the pulmonary emphysema.